Survival outcome of intermediate risk neuroblastoma at Children Cancer Hospital Egypt

ConclusionA very high rate of survival is currently achievable in patients with intermediate risk neuroblastoma by chemotherapy or chemotherapy and surgery. In addition to response, our plan is to adopt biologically-based treatment to reduce treatment-induced complications among survivors.
Source: Journal of the Egyptian National Cancer Institute - Category: Cancer & Oncology Source Type: research